LENHAPI Trademark

Trademark Overview

On Thursday, March 5, 2020, a trademark application was filed for LENHAPI with the United States Patent and Trademark Office. The USPTO has given the LENHAPI trademark a serial number of 88823342. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by Gilead Sciences Ireland UC. The LENHAPI trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
lenhapi

General Information

Serial Number88823342
Word MarkLENHAPI
Filing DateThursday, March 5, 2020
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7198389
Registration DateTuesday, October 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
Translation of Words in MarkThe wording "LENHAPI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Friday, September 15, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, September 6, 2023NOTICE OF ALLOWANCE CANCELLED
Wednesday, September 6, 2023TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, April 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 25, 2023SOU EXTENSION 5 GRANTED
Wednesday, April 19, 2023SOU EXTENSION 5 FILED
Monday, April 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 25, 2022SOU EXTENSION 4 GRANTED
Tuesday, October 25, 2022SOU EXTENSION 4 FILED
Tuesday, October 25, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, April 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 15, 2022SOU EXTENSION 3 GRANTED
Friday, April 15, 2022SOU EXTENSION 3 FILED
Friday, April 15, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 10, 2021ASSIGNED TO EXAMINER
Thursday, September 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 28, 2021SOU EXTENSION 2 GRANTED
Tuesday, September 28, 2021SOU EXTENSION 2 FILED
Tuesday, September 28, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 7, 2021SOU EXTENSION 1 FILED
Wednesday, April 7, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 1, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, August 28, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, August 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 4, 2020ASSIGNED TO LIE
Tuesday, July 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NON-FINAL ACTION WRITTEN
Sunday, May 24, 2020ASSIGNED TO EXAMINER
Wednesday, March 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 9, 2020NEW APPLICATION ENTERED

Related Keywords

lenhapi preparations pharmaceutical treatment disorders diseases anti respiratory autoimmune pulmonary kidney